Bio-Rad Laboratories (BIO) Enterprise Value (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Enterprise Value data on file, last reported at -$1.6 billion in Q1 2026.

• On a quarterly basis, Enterprise Value rose 5.76% year-over-year to -$1.6 billion in Q1 2026; TTM through Mar 2026 was -$1.6 billion, a 5.76% increase from a year earlier, with the FY2025 full-year figure at -$1.5 billion, up 7.44% from the prior year.
• Enterprise Value for Q1 2026 stood at -$1.6 billion, down from -$1.5 billion in the prior quarter.
• Over the last five years, Enterprise Value for BIO reached as high as -$412.5 million in Q2 2024 and fell as low as -$2.0 billion in Q2 2022.
• Historically, Enterprise Value has averaged -$1.4 billion across 5 years, with a median of -$1.6 billion in 2023.
• Across the five-year window, Enterprise Value surged 76.06% in 2024 and plunged 278.34% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$1.8 billion in 2022, then climbed by 10.25% to -$1.6 billion in 2023, then declined by 3.57% to -$1.7 billion in 2024, then advanced by 7.44% to -$1.5 billion in 2025, then fell by 1.56% to -$1.6 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$1.6 billion in Q1 2026, -$1.5 billion in Q4 2025, and -$1.4 billion in Q3 2025.